Literature DB >> 29187667

Strategy and Outcome of Catheter Ablation for Persistent Atrial Fibrillation - Impact of Progress in the Mapping and Ablation Technologies.

Hideharu Okamatsu1, Ken Okumura1.   

Abstract

Pulmonary vein (PV) antrum isolation (PVAI) is effective in treating paroxysmal atrial fibrillation (AF) but is less so for persistent AF. A recent randomized study on the ablation strategies for persistent AF demonstrated that 2 common atrial substrate modifications, creation of linear lesions in the left atrium and ablation of complex fractionated electrogram sites, in addition to PVAI did not improve the outcome compared with stand-alone PVAI, suggesting the necessity of a more individualized, selective approach to persistent AF. There are emerging technologies, including high-resolution mapping with the use of multi-electrode catheter and auto mapping system and contact force (CF) guide ablation; the former allows rapid and accurate confirmation of the completeness of PVAI, and the latter enhances the achievement of durable ablation lesions more securely. Ablation for fibrotic area(s) has been proposed as a new approach for substrate modification, and high-resolution mapping is useful to define the area with low-voltage electrograms, a surrogate marker for atrial fibrosis. Ablation for non-PV triggers in addition to PVAI improves the outcome of persistent AF. Further, durable isolation of the left atrial posterior wall may reduce AF recurrence. These ablation strategies with concomitant use of the emerging technologies are strongly expected to enhance the effectiveness of catheter ablation for persistent AF.

Entities:  

Keywords:  Catheter ablation; Catheter mapping technology; Contact force sensing; Persistent atrial fibrillation

Mesh:

Year:  2017        PMID: 29187667     DOI: 10.1253/circj.CJ-17-1205

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Esophageal pressure monitoring for airway management during catheter ablation of atrial fibrillation.

Authors:  Yu-Ki Iwasaki; Yuhi Fujimoto; Eiichiro Oka; Kanako Ito Hagiwara; Kenta Takahashi; Ippei Tsuboi; Hiroshi Hayashi; Kenji Yodogawa; Meiso Hayashi; Yasushi Miyauchi; Wataru Shimizu
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-27

2.  Strategies for repeat ablation for atrial fibrillation: A multicentre comparison of nonpulmonary vein versus pulmonary vein target ablation.

Authors:  Daniel Mol; Mark J Mulder; Rob Veenstra; Cornelis P Allaart; Irene E Hof; Michiel J B Kemme; Muchtiar Khan; Geert-Jan P Kimman; Gideon Mairuhu; Gijsbert S de Ruiter; Giovanni J M Tahapary; Joris R de Groot; Jonas S S G de Jong
Journal:  J Cardiovasc Electrophysiol       Date:  2022-03-22       Impact factor: 2.942

3.  Incidence, electrophysiological characteristics, and long-term follow-up of perimitral atrial flutter in patients with previously confirmed mitral isthmus block.

Authors:  Panagiotis Ioannidis; Evangelia Christoforatou; Theodoros Zografos; Panagiotis Charalambopoulos; Konstantinos Kouvelas; Georgios Christoulas; Periklis Syros; Georgios Tsitsinakis; Theodora Kappou; Andreas Tsoumeleas; Sotirios Floros; Dimitrios Tagoulis; Ioannis Ntarladimas; Ioannis Tagoulis; Dimitrios Avzotis; Antonis S Manolis; Charalambos Vassilopoulos
Journal:  J Arrhythm       Date:  2021-05-12

Review 4.  Catheter ablation for the management of atrial fibrillation: current technical perspectives.

Authors:  Kathryn Lauren Hong; Jazlyn Borges; Benedict Glover
Journal:  Open Heart       Date:  2020-05

5.  Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.

Authors:  Zefeng Wang; Liting Cheng; Junmeng Zhang; Zhuo Liang; Ruiqing Dong; Fei Hang; Xinlu Wang; Ziyu Wang; Yongquan Wu; Jie Du
Journal:  Med Sci Monit       Date:  2020-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.